Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the italian expanded access program

HIGHLIGHTS

• who: Elena Verzoni from the dei Tumori di Milano, Via Venezian, Milan, Italy have published the paper: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program, in the Journal: (JOURNAL)
• what: Given the controversy over the potential association of irAEs with favorable clinical outcomes and the discordant conclusions obtained in different cancer populations, here the authors report the results of a secondary analysis of the Italian EAP for nivolumab in mRCC patients, with the specific aim . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.